ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
2,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4,2,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
5,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
7,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
8,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,2,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
8,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
8,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
9,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
10,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
11,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
12,3,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
12,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
13,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
14,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
16,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
17,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
18,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
19,1,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
20,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
20,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
21,1,Gastrointestinal tract mucosal discolouration,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
21,2,Histiocytosis,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
21,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
22,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
22,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
22,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
22,4,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
23,1,Acoustic neuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
23,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
23,3,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
23,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
23,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
23,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
23,7,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
23,8,Neurilemmoma benign,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
23,9,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
24,1,Acoustic neuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
24,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
24,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
24,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
24,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
24,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
25,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
25,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
25,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
25,4,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
26,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
26,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
26,3,Neurilemmoma benign,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
26,4,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
27,1,Acoustic neuroma,Neuromas,Nervous system neoplasms benign,Neopl,N
27,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
27,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,4,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
28,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
29,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
29,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
29,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
30,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
31,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
32,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
34,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
35,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
36,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
37,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
38,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
39,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
40,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
41,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
41,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
41,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
41,5,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
41,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,7,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
42,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
42,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
42,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
42,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
42,5,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
42,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
43,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
43,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
43,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
44,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
44,2,Headache,Headaches NEC,Headaches,Nerv,N
44,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
44,4,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
44,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,6,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
44,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
45,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
45,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
45,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
46,1,Atypical mycobacterium test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
47,1,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
47,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
47,3,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
48,2,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,3,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
49,1,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
49,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
49,3,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
51,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
51,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
52,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
53,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
54,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
54,2,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
54,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
55,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,3,Tanning,Social issues NEC,Lifestyle issues,SocCi,N
56,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
